Tuesday, March 06, 2007

Lung cancer - Merck predicts a more robust 1Q profit


Merck predicts a more robust 1Q profit
Associated Press - Merck, the maker of osteoporosis treatment Fosamax and Singulair for asthma and allergies, also said it expects earnings per share of $2.55 to $2.65 for the full year, excluding restructuring charges. That's up from its Jan. 30 forecast of $2.51 to

Missing inaction
Boston Online - It could be homelessness, asthma. A lot of times, it's the parents. They're enablers." It's his job to worry. McLaughlin, 56, is a truant officer for the Boston public schools -- supervisor of attendance, according to his badge. "She's got a

Is Hidden Mold at Home Making You Sick?
ABC News - March 23 Except for an occasional asthma flare up, Caitlin Murray is a healthy, happy 5-year-old, who loves doing artwork. But three years ago, she was terribly sick, and no one could figure out why. "She would have terrible headaches and her face